Organovo Holdings, Inc. (ONVO)

[RandolRocketman]

Pfizer to invest $600 mln in venture capital arm
BY MarketWatch
— 8:14 AM ET 06/06/2018

Could be the precursor to this eventual buy out?

Best case scenario for us would be a bidding war between Pfizer and Merck or Sanofi or even Boston Scientific :)

Having said all that, ONVO under $2 IMO is still super cheap
Even if they have to go it alone on the liver patch, or kidney replacement therapy, the eventual value of transplant therapy is in the tens of billions. And from the looks of it, Organovo has the lion''s share of related IP, some good history of getting the patented technology working for testing , and the advantage of getting their technology in front of the FDA first.